secwatch.observer — SEC 8-K summary
======================================

Issuer:     KINGSWAY FINANCIAL SERVICES INC (KFS)
CIK:        0001072627
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0001437749-23-035570
Event type: m_and_a
Sentiment:  negative
Materiality: 0.65
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Kingsway terminates acquisition agreement for National Institute of Clinical Research due to seller breaches
--------------------------------------------------------------------------------

- Kingsway Buyer delivered written termination on Dec 23, 2023, citing uncured breaches by Seller and Shareholder.
- Agreement originally announced Oct 19, 2023, to acquire membership interest of National Institute of Clinical Research Inc.
- No termination fee or penalty mentioned; company does not disclose deal value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072627/000143774923035570/0001437749-23-035570-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072627/000143774923035570/kfs20231226_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-035570

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer